177Lu Lutetium

Radiochemicals

Lutetium-177

Request a Quote Ask a specialist

Availability
Weekly
Half life
6.7 days
Radionuclidic purity
Lu-177 > 99.95%
Concentration
100 mCi/mL
Regions
Canada · Latin America · USA

Lutetium is used in a radiation-based treatment that utilizes a molecule to attach itself to the PSMA receptors located on the cancer cells. Lutetium-177 emits beta radiation that effectively damages cancer cells and, over time, destroys them.Lu-177 C. A and Lu-177 N.C.A, we can provide you both products. In addition, we can provide both carrier-added and no-carrier-added Lu-177.

Weekly supply windows

Calibrated to your delivery date, shipped from qualified reactor and cGMP partners.

Regulatory support

DMF assistance and documentation for Canada, USA and Latin America filings.

Cold-chain logistics

Type A packaging, licensing and customs handled by our regional order desks.

Thinking… Something went wrong. Please try again.